The Singapore Food Agency (SFA) has officially released its exhaustive list of approved novel foods, a significant compilation that includes groundbreaking innovations such as cultivated meat and fermentation-derived proteins. This publication precedes further regulatory approvals, underscoring Singapore’s commitment to becoming a global hub for future food technologies. The list, detailing authorizations up to October 2025, serves as a testament to the nation’s proactive approach in establishing a robust framework for the burgeoning alternative protein sector.
Singapore’s consistent leadership in this domain is evidenced by its early adoption of regulatory pathways for novel food products. It was the first country to grant market clearance for cultivated meat and gas-fermented proteins, a pioneering move that has since inspired other nations. Industry projections suggest that a substantial pipeline of up to a dozen additional companies are actively seeking approval for their cultivated meat offerings in Singapore, indicating a robust and growing interest from global innovators.
However, the path for these alternative protein startups has not been without its challenges. Significant financial hurdles and complexities associated with scaling up production have, at times, placed these innovations on a less prominent footing within the nation’s broader food strategy. Environment Minister Grace Fu has previously cited "higher production costs and weaker-than-expected consumer acceptance globally" as factors influencing the current trajectory. Despite these considerations, the government’s continued focus on research and development (R&D) aims to enhance the sector’s competitiveness and mainstream adoption. The publication of this comprehensive novel foods list, therefore, signals that food technology remains a key strategic priority for Singapore.
A Detailed Look at Singapore’s Cultivated Meat Approvals
The SFA’s newly published list encompasses 14 distinct products and ingredients, with cultivated meat and algal protein featuring prominently alongside other fermentation-derived foods. Among these, four cultivated meat products have received official clearance.
Two of these approvals belong to Eat Just’s Good Meat brand. The company secured the world’s first regulatory approval for cultivated meat in Singapore in 2020, initially for its cultivated chicken. This initial product utilized fetal bovine serum, a component that has faced scrutiny within the industry. A subsequent approval in 2023 marked a significant advancement, authorizing a refined version of Good Meat chicken produced through a serum-free process, addressing a key area of concern for sustainable production.
More recently, in April 2024, the SFA granted approval to Australian startup Vow for its cultured quail. This innovative product has since been integrated into a diverse range of culinary applications, including parfaits and foie gras, and is currently available in 17 dining establishments across Singapore, showcasing its commercial viability and consumer acceptance in a gastronomic setting.
The list also features an October 2025 approval for Parima, a company formed through the merger of French cultivated meat pioneers Gourmey and Vital Meat. The initial approval, as previously reported, was for Vital Meat’s chicken product. Demonstrating ongoing innovation and expansion, Parima subsequently received a further endorsement this month for Gourmey’s cultivated duck innovation. This latest approval came just days after the publication of the novel foods list, signaling a swift regulatory process for established players. Parima intends to enter the Singaporean market through premium channels, with an initial focus on haute cuisine establishments, followed by a targeted retail expansion.
Beyond human food applications, Singapore has also facilitated the approval of Friends & Family Pet Food Company’s cell-cultured Kampung bird ingredient. This ingredient is designated for use in dog and cat treats, falling under the purview of the Singapore Animal & Veterinary Service (SAVS), which collaborates with the SFA on related regulatory matters.
Innovations in Algae and Microbial Fermentation
Beyond the realm of cultivated meat, the SFA’s list highlights seven approvals within the fermentation category, representing significant advancements in the utilization of algae and microbial processes for food production.
The inaugural novel food clearance by the SFA was for Triton Algae Innovations’ dried green algae ingredient, approved in May 2019. This versatile green powder serves as a potent protein-boosting additive across a wide spectrum of food and beverage applications, including nutritional supplements, pasta, juices, and protein bars. Triton Algae also received a subsequent approval in 2022 for its red algae ingredient, particularly well-suited for enhancing the texture and flavor of plant-based meat alternatives.
Bridging these two approvals was the 2021 clearance of Fy protein, an ingredient developed by U.S. startup Nature’s Fynd. This unique protein is derived from a fungal strain discovered in the geysers of Yellowstone National Park, stemming from research initially conducted for NASA. Nature’s Fynd has already launched products such as yogurts and sausage patties incorporating this fungal protein in the United States, demonstrating its potential for diverse product development.
Another noteworthy approval is for Solar Foods’ Solein protein. This innovative ingredient is produced through a unique process where microbes are fed greenhouse gases, such as carbon, rather than traditional sugars. The resulting bright yellow powder has been incorporated into a variety of products and dishes in Singapore, including gelato, iced lattes, mooncakes, and ice cream sandwiches, showcasing its adaptability and consumer appeal.
The year 2024 saw the SFA grant two approvals for mycoprotein. The first was for The Better Meat Co’s Rhiza ingredient, a versatile mycoprotein suitable for use in meat analogues, as well as an ‘enhancer’ in dairy products and blended meat applications. The second approval was for Fermotein, a whole-cell bioproduct developed by Dutch startup The Protein Brewery. Fermotein is positioned as a key ingredient for a range of meat and dairy alternatives.
Finally, the SFA has also approved the sale of a mycelium ingredient derived from the Pleurotus pulmonarius strain, commonly known as the lung oyster or phoenix mushroom. This approval, granted in 2025, indicates continued expansion of fungal-based protein sources, though the specific company responsible for this application remains to be detailed in public announcements.
Strategic Implications and Future Outlook
The SFA’s comprehensive publication of its novel foods list signifies more than just a regulatory update; it represents a strategic affirmation of Singapore’s commitment to fostering innovation in the sustainable protein sector. By providing clear regulatory pathways and actively approving new technologies, Singapore positions itself as an attractive destination for R&D and commercialization in the alternative protein space.
The inclusion of cultivated meat and a diverse array of fermentation-derived proteins underscores the agency’s forward-thinking approach. This regulatory clarity is crucial for attracting investment, encouraging further research, and building consumer trust in these novel food categories. While challenges related to cost and consumer perception persist globally, Singapore’s proactive stance suggests a long-term vision for a more resilient and sustainable food system.
The timeline of approvals, stretching from 2019 to a forward-looking 2025, illustrates a consistent and evolving regulatory landscape. Each approved product represents a step towards diversifying protein sources and reducing reliance on traditional agriculture, which faces increasing environmental pressures. The involvement of both established players like Eat Just and emerging innovators such as Vow and Nature’s Fynd highlights the dynamic nature of this industry and Singapore’s role as an enabler of its growth.
The inclusion of mycoprotein and algae-based proteins alongside cultivated meat demonstrates a broad understanding of the multifaceted nature of sustainable protein development. These ingredients offer different functional properties and production methodologies, contributing to a more comprehensive and adaptable future food supply chain.
The fact that Singapore was the first country to approve cultivated meat for sale, and continues to be a leader in novel food regulation, provides valuable insights for other nations grappling with similar policy questions. The SFA’s approach, balancing innovation with stringent safety assessments, offers a potential blueprint for global food governance in the 21st century. As the list expands and more companies seek approval, Singapore is poised to further solidify its position as a vital nexus for the future of food. The ongoing R&D efforts, coupled with strategic regulatory frameworks, are expected to drive down production costs and foster greater consumer acceptance, ultimately contributing to a more sustainable and secure global food future.